VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q2 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,721,998 | -9.8% | 63,991 | +1.0% | 0.38% | -8.4% |
Q2 2023 | $1,908,101 | -7.3% | 63,371 | -0.4% | 0.42% | -16.0% |
Q1 2023 | $2,058,625 | +12.8% | 63,636 | +0.0% | 0.50% | +10.2% |
Q4 2022 | $1,825,527 | +123.4% | 63,611 | +87.8% | 0.45% | +101.3% |
Q3 2022 | $817,000 | -17.0% | 33,873 | -5.7% | 0.22% | -9.0% |
Q2 2022 | $984,000 | -30.4% | 35,928 | -2.5% | 0.24% | -18.1% |
Q1 2022 | $1,413,000 | +20.1% | 36,834 | +0.2% | 0.30% | +8.3% |
Q4 2021 | $1,177,000 | -9.0% | 36,749 | -16.3% | 0.28% | -16.9% |
Q3 2021 | $1,294,000 | -15.3% | 43,894 | -2.3% | 0.33% | -11.5% |
Q2 2021 | $1,527,000 | -7.7% | 44,943 | -11.8% | 0.38% | -18.5% |
Q1 2021 | $1,655,000 | -10.4% | 50,935 | -0.6% | 0.46% | -17.4% |
Q4 2020 | $1,847,000 | -10.8% | 51,265 | -3.1% | 0.56% | -22.4% |
Q3 2020 | $2,071,000 | -1.5% | 52,895 | -7.7% | 0.72% | -12.4% |
Q2 2020 | $2,102,000 | +52.0% | 57,317 | -4.5% | 0.82% | +30.0% |
Q1 2020 | $1,383,000 | – | 60,044 | – | 0.63% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |